JPWO2023022216A1 - - Google Patents

Info

Publication number
JPWO2023022216A1
JPWO2023022216A1 JP2023542451A JP2023542451A JPWO2023022216A1 JP WO2023022216 A1 JPWO2023022216 A1 JP WO2023022216A1 JP 2023542451 A JP2023542451 A JP 2023542451A JP 2023542451 A JP2023542451 A JP 2023542451A JP WO2023022216 A1 JPWO2023022216 A1 JP WO2023022216A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023542451A
Other languages
Japanese (ja)
Other versions
JPWO2023022216A5 (cg-RX-API-DMAC7.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023022216A1 publication Critical patent/JPWO2023022216A1/ja
Publication of JPWO2023022216A5 publication Critical patent/JPWO2023022216A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP2023542451A 2021-08-20 2022-08-19 Pending JPWO2023022216A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021134801 2021-08-20
PCT/JP2022/031308 WO2023022216A1 (ja) 2021-08-20 2022-08-19 ウイルス増殖抑制作用を有するヌクレオシド誘導体及びそれらのプロドラッグ

Publications (2)

Publication Number Publication Date
JPWO2023022216A1 true JPWO2023022216A1 (cg-RX-API-DMAC7.html) 2023-02-23
JPWO2023022216A5 JPWO2023022216A5 (cg-RX-API-DMAC7.html) 2025-08-18

Family

ID=85240607

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023542451A Pending JPWO2023022216A1 (cg-RX-API-DMAC7.html) 2021-08-20 2022-08-19

Country Status (13)

Country Link
US (1) US20250170155A1 (cg-RX-API-DMAC7.html)
EP (1) EP4389750A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023022216A1 (cg-RX-API-DMAC7.html)
KR (1) KR20240050362A (cg-RX-API-DMAC7.html)
CN (1) CN118119624A (cg-RX-API-DMAC7.html)
AU (1) AU2022331233A1 (cg-RX-API-DMAC7.html)
CA (1) CA3229752A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024003018A2 (cg-RX-API-DMAC7.html)
IL (1) IL310854A (cg-RX-API-DMAC7.html)
MX (1) MX2024002116A (cg-RX-API-DMAC7.html)
PE (1) PE20240654A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023022216A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202401270B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7559223B2 (ja) 2020-08-24 2024-10-01 ギリアード サイエンシーズ, インコーポレイテッド リン脂質化合物及びその使用
US11926645B2 (en) 2020-08-27 2024-03-12 Gilead Sciences, Inc. Compounds and methods for treatment of viral infections
TWI925033B (zh) 2020-10-16 2026-05-11 美商基利科學股份有限公司 磷脂化合物及其用途
KR20240154647A (ko) 2022-03-02 2024-10-25 길리애드 사이언시즈, 인코포레이티드 바이러스성 감염 치료를 위한 화합물 및 방법
EP4547665A1 (en) 2022-06-30 2025-05-07 Gilead Sciences, Inc. Solid forms of a nucleoside analogue and uses thereof
US12357577B1 (en) 2024-02-02 2025-07-15 Gilead Sciences, Inc. Pharmaceutical formulations and uses thereof
WO2026160341A1 (ja) * 2025-01-21 2026-07-30 塩野義製薬株式会社 ウイルス感染治療用アザ糖誘導体

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016504284A (ja) * 2012-11-16 2016-02-12 バイオクリスト ファーマスーティカルズ,インコーポレイテッドBiocryst Pharmaceuticals,Inc. 抗ウイルス性アザ糖を含有するヌクレオシド
JP2019069986A (ja) * 2012-03-13 2019-05-09 ギリアード サイエンシーズ, インコーポレイテッド 抗ウイルス処置のための2’−置換カルバヌクレオシド類似体
JP2020534361A (ja) * 2017-09-18 2020-11-26 ヤンセン・バイオファーマ・インコーポレイテッド 置換ヌクレオシド、ヌクレオチド、及びそのアナログ

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0071227B1 (en) 1981-07-31 1987-11-11 Sloan-Kettering Institute For Cancer Research Anti-leukemic beta-glycosyl c-nucleosides
US5985848A (en) 1997-10-14 1999-11-16 Albert Einstein College Of Medicine Of Yeshiva University Inhibitors of nucleoside metabolism
WO2002018371A1 (en) 2000-08-29 2002-03-07 Industrial Research Limited Nucleoside metabolism inhibitors
US7098334B2 (en) 2002-03-25 2006-08-29 Industrial Research Limited 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
BR0309581A (pt) 2002-05-06 2005-03-29 Genelabs Tech Inc Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
SG182849A1 (en) 2003-04-25 2012-08-30 Gilead Sciences Inc Antiviral phosphonate analogs
WO2005123087A2 (en) 2004-06-15 2005-12-29 Merck & Co., Inc. C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
US7560434B2 (en) 2004-06-22 2009-07-14 Biocryst Pharmaceuticals, Inc. AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
AU2005302448B2 (en) 2004-10-29 2012-07-19 Biocryst Pharmaceuticals, Inc. Therapeutic furopyrimidines and thienopyrimidines
WO2007069924A1 (en) 2005-12-15 2007-06-21 Industrial Research Limited Deazapurine analogs of 4'-aza-l-nucleosides
NZ598927A (en) 2007-01-12 2013-09-27 Biocryst Pharm Inc Antiviral nucleoside analogs
DK2155758T3 (da) 2007-05-10 2012-11-05 Biocryst Pharm Inc Tetrahydrofuro[3,4-d]dioxolanforbindelser til anvendelse i behandlingen af virusinfektioner og cancer
EP2313102A2 (en) 2008-07-03 2011-04-27 Biota Scientific Management Bycyclic nucleosides and nucleotides as therapeutic agents
TW201305185A (zh) 2010-09-13 2013-02-01 吉李德科學股份有限公司 用於抗病毒治療之2’-氟取代之碳-核苷類似物
US9290501B2 (en) 2010-11-29 2016-03-22 Albert Einstein College Of Medicine, Inc. Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase
AR090699A1 (es) 2012-04-18 2014-12-03 Biocryst Pharm Inc Compuestos inhibidores de la actividad de la arn polimerasa viral
WO2014035140A2 (en) 2012-08-30 2014-03-06 Kainos Medicine, Inc. Compounds and compositions for modulating histone methyltransferase activity
WO2014093924A1 (en) 2012-12-13 2014-06-19 Moderna Therapeutics, Inc. Modified nucleic acid molecules and uses thereof
AU2014265483B2 (en) 2013-05-14 2018-08-02 Biocryst Pharmaceuticals, Inc. Anti-influenza compositions and methods
UA119050C2 (uk) 2013-11-11 2019-04-25 Ґілеад Саєнсиз, Інк. ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
WO2015143712A1 (en) 2014-03-28 2015-10-01 Merck Sharp & Dohme Corp. 4'-substituted nucleoside reverse transcriptase inhibitors
TWI698444B (zh) 2014-10-29 2020-07-11 美商基利科學股份有限公司 製備核糖苷的方法
CA2966033A1 (en) 2014-10-31 2016-05-06 Cocrystal Pharma, Inc. 2',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
JPWO2018199048A1 (ja) 2017-04-25 2020-05-07 大原薬品工業株式会社 ヌクレオシド系抗がん剤または抗ウィルス剤の5’位モノ燐酸ジベンジルエステル誘導体
WO2018230479A1 (ja) 2017-06-13 2018-12-20 大原薬品工業株式会社 ヌクレオシド系抗がん剤又は抗ウィルス剤の5'位シリルエーテル誘導体
EP3737359A4 (en) 2018-01-12 2021-11-03 Board of Regents of the University of Nebraska ANTIVIRAL PRODRUGS AND THEIR FORMULATIONS
WO2021040356A1 (en) 2019-08-23 2021-03-04 Kainos Medicine, Inc. C-nucleosides, c-nucleotides and their analogs, equivalents and prodrugs thereof for ectonucleotidase inhibition
CN112778310B (zh) 2020-04-20 2025-05-30 中国科学院上海药物研究所 核苷类似物或含有核苷类似物的组合制剂在抗病毒中的应用
CN112062800B (zh) 2020-09-02 2022-11-18 广东东阳光药业有限公司 核苷化合物的氨基磷酸酯衍生物及其用途
CN112010916B (zh) 2020-09-09 2022-12-27 广东东阳光药业有限公司 核苷化合物的氨基磷酸酯衍生物及其用途

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019069986A (ja) * 2012-03-13 2019-05-09 ギリアード サイエンシーズ, インコーポレイテッド 抗ウイルス処置のための2’−置換カルバヌクレオシド類似体
JP2016504284A (ja) * 2012-11-16 2016-02-12 バイオクリスト ファーマスーティカルズ,インコーポレイテッドBiocryst Pharmaceuticals,Inc. 抗ウイルス性アザ糖を含有するヌクレオシド
JP2020534361A (ja) * 2017-09-18 2020-11-26 ヤンセン・バイオファーマ・インコーポレイテッド 置換ヌクレオシド、ヌクレオチド、及びそのアナログ

Also Published As

Publication number Publication date
ZA202401270B (en) 2026-05-27
MX2024002116A (es) 2024-03-06
EP4389750A1 (en) 2024-06-26
CO2024003018A2 (es) 2024-03-18
PE20240654A1 (es) 2024-04-04
AU2022331233A1 (en) 2024-02-29
CA3229752A1 (en) 2023-02-23
KR20240050362A (ko) 2024-04-18
IL310854A (en) 2024-04-01
WO2023022216A1 (ja) 2023-02-23
US20250170155A1 (en) 2025-05-29
EP4389750A4 (en) 2025-10-01
CN118119624A (zh) 2024-05-31

Similar Documents

Publication Publication Date Title
BR112023012656A2 (cg-RX-API-DMAC7.html)
BR102020021170B1 (pt) Composição, formulações orais e uso
BR102020004560B1 (pt) Rotor eólico utilizando duplas-pás inteiriças para geração de potência
CN305937031S (zh) 酒桶(自烤酒)
CN305923515S (zh) Usb投影灯(l-1)
CN305940999S (zh) 吊灯(8508)
CN305932941S (zh) 摆件(仙桃筶杯)
CN305929630S (zh) 端头连接件
CN305907180S (zh) 手电筒(x73)
CN305904739S (zh) 数据中心一体化机柜(003)
CN305935948S (zh) 转角柜
CN305925933S (zh) 水壶(棱形)
CN305856819S (zh) 桌子(sl-1塑料学习桌)
CN305905649S (zh) 书籍封面
CN305909271S (zh) 圆餐桌(hz9930)
CN305925289S (zh) 休闲几(hx9930)
CN305914225S (zh) 灭蚊器(dh-mw10)
CN305860998S (zh) 实训台(工业机器人上下料通用)
CN305927522S (zh) 花盆(xw-1818)
CN305911994S (zh) 车把(q5)
CN305857215S (zh) 茶杯套件
CN305852244S (zh) 地板清洁机夹具
CN305908823S (zh) 纺织面料(jtm166-1)
CN305922170S (zh) 压力桶(内置式)
CN305907801S (zh) 彩妆盘(鹤禧觉色·岁朝清供一)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250804

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250804

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260526

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260724